References

1. Aldea GS, O'Gara P, Shapira OM, Treanor P, Osman A, Patalis E, Arkin C, Diamond R, Babikian V, Lazar HL, Shemin RJ. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Ann Thorac Surg. 1998 Feb;65(2):425-33.

2. Aldea GS, Doursounian M, O'Gara P, Treanor P, Shapira OM, Lazar HL, Shemin RJ.Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study. Ann Thorac Surg. 1996 Aug;62(2):410-7.

3. Baufreton C, de Brux JL, Binuani P, Corbeau JJ, Subayi JB, Daniel JC, Treanor P. A combined approach for improving cardiopulmonary bypass in coronary artery surgery: a pilot study. Perfusion. 2002 Nov;17(6):407-13.

4. Aldea GS et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002;123:742-55.

5. De Somer F, Van Belleghem Y, Caes F, Francois K, Van Overbeke H, Arnout J, Taeymans Y, Van Nooten G. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2002 May;123(5):951-8.

6. Pierangeli A, Masieri V, Bruzzi F, De Toni E, Grillone G, Boni P, Delnevo A. Haemolysis during cardiopulmonary bypass: how to reduce the free haemoglobin by managing the suctioned blood separately. Perfusion. 2001 Nov;16(6):519-24.

7. Walpoth BH, Eggensperger N, Hauser SP, Neidhart P, Kurt G, Spaeth PJ, Althaus U. Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery. Int J Artif Organs. 1999;22(4):210-6.

8. Spanier T, Tector K, Schwartz G, Chen J, Oz M, Beck J, Mongero L. Endotoxin in pooled pericardial blood contributes to the systemic inflammatory response during cardiac surgery. Perfusion. 2000 Sep;15(5):427-31.

9. Jewell AE, Akowuah EF, Suvarna SK, Braidley P, Hopkinson D, Cooper G. A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. Eur J Cardiothorac Surg. 2003 Apr;23(4):633-6.

10. Kaza AK, Cope JT, Fiser SM, Long SM, Kern JA, Kron IL, Tribble CG. Elimination of fat microemboli during cardiopulmonary bypass. Ann Thorac Surg. 2003 Feb;75(2):555-9.

11. Brooker RF, Brown WR, Moody DM, Hammon JW Jr, Reboussin DM, Deal DD, Ghazi-Birry HS, Stump DA. Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg. 1998 Jun;65(6):1651-5.

12. Kincaid EH, Jones TJ, Stump DA, Brown WR, Moody DM, Deal DD, Hammon JW Jr. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization. Ann Thorac Surg. 2000 Oct;70(4):1296-300.

13. Appelblad M, Engstrom G. Fat contamination of pericardial suction blood and its influence on in vitro capillary-pore flow properties in patients undergoing routine coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2002 Aug;124(2):377-86.

14. Leyh RG, Bartels C, Notzold A, Sievers HH. Management of porcelain aorta during coronary artery bypass grafting. Ann Thorac Surg. 1999 Apr;67(4):986-8

15. Grocott HP, Croughwell ND, Amory DW, White WD, Kirchner JL, Newman MF. Cerebral emboli and serum S100beta during cardiac operations. Ann Thorac Surg. 1998 Jun;65(6):1645-9.

16. Mullges W, Franke D, Reents W, Babin-Ebell J. Brain microembolic counts during extracorporeal circulation depend on aortic cannula position. Ultrasound Med Biol. 2001 Jul;27(7):933-6.

17. Borger MA, Taylor RL, Weisel RD, Kulkarni G, Benaroia M, Rao V, Cohen G, Fedorko L, Feindel CM. Decreased cerebral emboli during distal aortic arch cannulation: a randomized clinical trial. J Thorac Cardiovasc Surg. 1999 Oct;118(4):740-5.

18. Calafiore AM, Di Mauro M, Teodori G, Di Giammarco G, Cirmeni S, Contini M, Iaco AL, Pano M. Impact of aortic manipulation on incidence of cerebrovascular accidents after surgical myocardial revascularization. Ann Thorac Surg. 2002 May;73(5):1387-93.

19. Barbut D, Hinton RB, Szatrowski TP, Hartman GS, Bruefach M, Williams-Russo P, Charlson ME, Gold JP. Cerebral emboli detected during bypass surgery are associated with clamp removal. Stroke. 1994 Dec;25(12):2398-402.

20. Grega MA, Borowicz LM, Baumgartner WA. Impact of single clamp versus double clamp technique on neurologic outcome. Ann Thorac Surg. 2003 May;75(5):1387-91.

21. Muehrcke DD, Cornhill JF, Thomas JD, Cosgrove DM. Flow characteristics of aortic cannulae. J Card Surg. 1995 Jul;10(4 Suppl):514-9.

22. Weinstein GS. Left hemispheric strokes in coronary surgery: implications for end-hole aortic cannulas. Ann Thorac Surg. 2001 Jan;71(1):128-32.

23. Grooters RK, Ver Steeg DA, Stewart MJ, Thieman KC, Schneider RF. Echocardiographic comparison of the standard end-hole cannula, the soft-flow cannula, and the dispersion cannula during perfusion into the aortic arch. Ann Thorac Surg. 2003 Jun;75(6):1919-23.

24. Larm O, et al. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomat Med Dev Art Org 1983;11:161-8.

25. Svenmarker S, et al. Neurological and general outcome in low-risk coronary artery bypass patients using heparin coated circuits. Eur J Cardiothorac Surg 2001;19:47-53.

26. Mahoney CB, et al. Transfusion after coronary artery bypass surgery: the impact of heparin bonded circuits. Eur J Cardiothorac Surg 1999;16:206-210.

27. Elgue G, et al. Effect of surface-immobilized heparin on the activation of adsorbed Factor XII. Artif Organs 1993;17:721-726.

28. Videm V, et al. In-vitro comparison of the heparin-coated and uncoated oxygenator circuits and 50% reduction of heparin dose. J Thorac Cardiovasc Surg 1991;101:654-6.

29. Larm O, et al. An approach to anti-thrombosis by surface modification. Progress in Artificial Organs 1985. Cleveland: ISAIO Press 1986;313-8.

30. Olsson P. Non-thrombogenic systems for extracorporeal gas exchange. Int J Artif Organs 1990;13:9.

31. Larsson R, et al. The search for thromboresistance using immobilized heparin. Blood in contact with natural and artificial surfaces. Ann NY Acad Sci 1987;516:102-115.

32. Belboul A, et al. Does heparin coating improve biocompatibility?: A study on complement, blood cells and postoperative morbidity during cardiac surgery. Perfusion 1997;12:385-391.

33. Borowiec J, et al. Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation. Cardiovasc Surg 1997;5:568-73.

34. Kagisaki K, et al. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass. Artif Organs 1997;21:836-40.

35. Lundblad R, et al. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997;63:1361-7.

36. Videm V, et al. Reduced granulocyte activation with heparin coated device in an invitro model of cardiopulmonary bypass. Artif Organs 1991;15:90-5.

37. Borowiec J, et all. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass - a clinical study. J Thor Cardiovasc Surg 1992;104:642-7.

38. Fukutomi M, et al. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment. Artif Organs 1996;20:767-76.

39. Mollnew T, et al. Formation of C5a during cardiopulmonary bypass. Ann Thorac Surg 1991;52:92-7.

40. Mahoney CB. Heparin-bonded circuits: clinical outcomes and costs. Perfusion 1998;13:192-204.

41. McCusker K, Vijay V, DeBois W, Helm R, Sisto D. MAST system: a new condensed cardiopulmonary bypass circuit for adult cardiac surgery. Perfusion. 2001 Nov;16(6):447-52.

42. Despotis GJ, Joist JH, Hogue CW Jr, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 1995 Jul;110(1):46-54.

43. Balachandran S, Cross MH, Karthikeyan S, Mulpur A, Hansbro SD, Hobson P. Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery. Ann Thorac Surg. 2002 Jun;73(6):1912-8

44. Eising GP, Pfauder M, Niemeyer M, Tassani P, Schad H, Bauernschmitt R, Lange R. Retrograde autologous priming: is it useful in elective on-pump coronary artery bypass surgery? Ann Thorac Surg. 2003 Jan;75(1):23-7.

45. Rosengart TK, DeBois W, O'Hara M, Helm R, Gomez M, Lang SJ, Altorki N, Ko W, Hartman GS, Isom OW, Krieger KH. Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg. 1998 Feb;115(2):426-38.

46. Shapira OM, Aldea GS, Treanor PR, Chartrand RM, DeAndrade KM, Lazar HL, Shemin RJ. Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume. Ann Thorac Surg. 1998 Mar;65(3):724-30

47. Cook DJ. Changing temperature management for cardiopulmonary bypass. Anesth Analg. 1999 Jun;88(6):1254-71.

48. Whitaker DC, Stygall JA, Newman SP, Harrison MJ. The use of leucocyte-depleting and conventional arterial line filters in cardiac surgery: a systematic review of clinical studies. Perfusion. 2001 Nov;16(6):433-46.

49. Merkle F, Bottcher W, Hetzer R. Prebypass filtration of cardiopulmonary bypass circuits: an outdated technique? Perfusion. 2003 Mar;18 Suppl 1:81-8.

50. Boivie P, Hansson M, Engstrom KG. Embolic material generated by multiple aortic crossclamping: A perfusion model with human cadaveric aorta. J Thorac Cardiovasc Surg. 2003 Jun;125(6):1451-60.

51. Karamanoukian HL, Pande RU. Key references: coronary artery bypass surgery and stroke. Heart Surg Forum. 2003;6(2):124-5.

52. Cirri S, Negri L, Babbini M, Latis G, Khlat B, Tarelli G, Panisi P, Mazzaro E, Bellisario A, Borghetti B, Bordignon F, Ferrara M, Pavan H, Meco M. Haemolysis due to active venous drainage during cardiopulmonary bypass: comparison of two different techniques. Perfusion. 2001 Jul;16(4):313-8.

53. Jegger D, Tevaearai HT, Horisberger J, Mueller XM, Boone Y, Pierrel N, Seigneul I, von Segesser LK. Augmented venous return for minimally invasive open heart surgery with selective caval cannulation. Eur J Cardiothorac Surg. 1999 Sep;16(3):312-6.

54. Toomasian JM, McCarthy JP. Total extrathoracic cardiopulmonary support with kinetic assisted venous drainage: experience in 50 patients. Perfusion. 1998 Mar;13(2):137-43.

55. Laurie, A, et al. The Society of Thoracic Surgery 30-day Operative Mortality and Morbidity Risk Models, Ann Thorac Surgery, 2003 Jun 75 (6):1856-64.

56. Data on file—Medtronic.

57. Hammon JW, et al. Risk factors and solutions for the development of neurobehavioral changes after coronary artery bypass grafting. Ann Thorac Surg 1997;63:1613-8.

58. Borger MA, Feindel CM. Cerebral emboli during cardiopulmonary bypass: effect of perfusionist interventions and aortic cannulas. J Extra Corpor Technol Mar 2002;34(1):29-33.

59. Hammon JW, et al. Approaches to reduce neurologic complications during cardiac surgery. Semin Thorac Cardiovasc Surg 2001;13(2):184-91.

60. Murkin JM. The role of CPB management in neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg 1995;59(5):1308-11.

61. Svenmarker, S, et al. Use of heparinbonded circuits in cardiopulmonary bypass improves clinical outcome. Scand Cardiovasc J 2002;35:241-246.

62. Heyer EJ, et al. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction. J Cardiothorac Vasc Anesth 2002;16(1):37-42.